

Prof. Dr. med. Peter J. Wild
pathology
pathology
Overview
Country, City
Germany, Frankfurt am Main
Health facility
University Hospital Frankfurt am Main
Medical unit
Dr. Senckenberg institute of pathology
About the doctor
Gallery






CDS systems in pathology | Elsevier Clinical Solutions Symposium, Frankfurt 2019
Resume
CV (Curriculum Vitae)
Education
- Studied medicine at the University of Regensburg
- Specialist training in pathology in Regensburg, Hamburg-Eppendorf, and Zurich
- Postgraduate program in medical biometry at the University of Heidelberg
- Postdoctoral research fellow at the Institute of Cell Biology at ETH Zurich, where he investigated the molecular mechanisms of prostate cancer development
- 2010 Postdoctoral lecturing qualification (Habilitation) in pathology
Experience
- Senior physician at the Institute of Pathology and Molecular Pathology at the University Hospital Zurich
- 2012 Became Assistant Professor (tenure track) for Systems Pathology
- 2016 Associate Professor and Associate Professor of Systems Pathology at the University Hospital Zurich
- Established and directed the High-Throughput Genomics and Proteomics Laboratory at the University Hospital Zurich
- 2018 Director of the Dr. Senckenberg Institute of Pathology (SIP) at Frankfurt University Hospital
- 2019 consultant pathologist at WILDLAB, specializing in uropathology and molecular pathology
- Professor at Goethe University Frankfurt
- 2020 Senior Fellow at the Frankfurt Institute for Advanced Studies (FIAS)
Awards & Memberships
- 2013 Received the Rudolf Virchow Prize of the German Society for Pathology in 2013 for his research
- Member of numerous medical societies and supervises many doctoral and postdoctoral students
Languages
English
German
Publications
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
30 December, 2025
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
May, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
March, 2024
Location
Theodor-Stern-Kai, 7, 60596 Frankfurt am Main, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Peter J. Wild?
The primary specialization of the doctor is pathology.
What is the rating of the doctor?
Prof. Dr. med. Peter J. Wild is rated as 9.50 by AiroMedical.
Prof. Dr. med. Peter J. Wild
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Peter J. Wild